[go: up one dir, main page]

WO2008008628A3 - Crystal structure of itpk1 and uses thereof - Google Patents

Crystal structure of itpk1 and uses thereof Download PDF

Info

Publication number
WO2008008628A3
WO2008008628A3 PCT/US2007/072280 US2007072280W WO2008008628A3 WO 2008008628 A3 WO2008008628 A3 WO 2008008628A3 US 2007072280 W US2007072280 W US 2007072280W WO 2008008628 A3 WO2008008628 A3 WO 2008008628A3
Authority
WO
WIPO (PCT)
Prior art keywords
itpk1
crystal structure
coordinates
studying
crystallized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/072280
Other languages
French (fr)
Other versions
WO2008008628A2 (en
Inventor
Philip Chamberlain
Glen Spraggon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IRM LLC
Original Assignee
IRM LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IRM LLC filed Critical IRM LLC
Publication of WO2008008628A2 publication Critical patent/WO2008008628A2/en
Publication of WO2008008628A3 publication Critical patent/WO2008008628A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/9121Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

The invention provides a crystallized ITPK1 molecule. The three-dimensional coordinates of the crystal structure of ITPK1 are obtained by X-ray diffraction. The coordinates can be used for studying the ITPK1 structure and designing, screening and developing compounds that modulate ITPK1 activity.
PCT/US2007/072280 2006-07-14 2007-06-27 Crystal structure of itpk1 and uses thereof Ceased WO2008008628A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83088306P 2006-07-14 2006-07-14
US60/830,883 2006-07-14

Publications (2)

Publication Number Publication Date
WO2008008628A2 WO2008008628A2 (en) 2008-01-17
WO2008008628A3 true WO2008008628A3 (en) 2008-05-02

Family

ID=38924010

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/072280 Ceased WO2008008628A2 (en) 2006-07-14 2007-06-27 Crystal structure of itpk1 and uses thereof

Country Status (1)

Country Link
WO (1) WO2008008628A2 (en)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHAMBERLAIN PHILIP P ET AL: "Integration of inositol phosphate signaling pathways via human ITPK1", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 38, September 2007 (2007-09-01), pages 28117 - 28125, XP002468067, ISSN: 0021-9258 *
GILLILAND G L ET AL: "The Biological Macromolecule Crystallization Database: crystallization procedures and strategies", ACTA CRYSTALLOGRAPHICA SECTION D: BIOLOGICAL CRYSTALLOGRAPHY, MUNKSGAARD PUBLISHERS LTD. COPENHAGEN, DK, 2002, pages 916 - 920, XP003012812, ISSN: 0907-4449 *
JHOTI H: "High-throughput structural proteomics using x-rays", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 19, no. 10, 1 October 2001 (2001-10-01), pages S67 - S71, XP004310381, ISSN: 0167-7799 *
MILLER GREGORY J ET AL: "Specificity determinants in inositol polyphosphate synthesis: Crystal structure of inositol 1,3,4-trisphosphate 5/6-kinase", MOLECULAR CELL, vol. 18, no. 2, April 2005 (2005-04-01), pages 201 - 212, XP002468066, ISSN: 1097-2765 *
WILSON M P ET AL: "Isolation of inositol 1,3,4-triphosphate 5/6-kinase, cDNA cloning and expression of the recombinant enzyme", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 271, no. 20, 17 May 1996 (1996-05-17), pages 11904 - 11910, XP002974240, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2008008628A2 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
WO2008109871A3 (en) Crystal structure of proprotein convertase 9 (pcsk9) and uses thereof
PL1795576T3 (en) Process for the manufacture of hydrocarbons
HUE042328T2 (en) Process for the preparation of a branched hydrocarbon component
EP1853313A4 (en) HUMANIZED ANTIBODIES L243
IL185110A0 (en) Processes for the production of organometallic compounds
IL184343A0 (en) Gitr antibodies for the diagnosis of nsclc
PL1947933T5 (en) System for controlled application of herbicides
DE602006003238D1 (en) Error fogging for video signals
WO2008008628A3 (en) Crystal structure of itpk1 and uses thereof
WO2007134262A3 (en) Crystal structure of prostasin and uses thereof
WO2008143894A3 (en) Phosphorylated rala
WO2006074464A3 (en) Modulating toll-like receptor activity
GB0505861D0 (en) Methods for the synthesis of heteroaromatic compounds
HK40116860A (en) Antibodies against cd38 for treatment of multiple myeloma
EP1846425A4 (en) Processes for the production of organometallic compounds
HK1121736A (en) Modulators of the h3 receptor useful for the treatment of disorders related thereto
FR2911703B1 (en) METHOD FOR MODELING THE ACOUSTIC RADIATION OF A COMPLEX STRUCTURE.
HK1109895A (en) 1,2-dihydro-spiro(3h-indole-3-4 -piperidine) compounds as modulators of the mas receptor novel
WO2009115664A3 (en) Crystalline structure of the cc2-lz domain of nemo
FI20055664A0 (en) Process for the preparation of a branched hydrocarbon component
AU2007905420A0 (en) Method for screening compounds that regulate phosphatase activity
HK1110673A (en) Forming information for the calendar application of an electronic device
AU2005904134A0 (en) The e-phantasia software for subject learning
HK1114102A (en) Non-steroidal compounds useful as glucocorticoid receptor modulators
AU2006902897A0 (en) Airborne seismic vibrating plate

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07812389

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07812389

Country of ref document: EP

Kind code of ref document: A2